DSC06980

DSC06980



(A) ethpsuximidę (B) Phenobarbital (C) yigabatrin fDj clonazepam (E) yalproic acid . 40 Which br the following drugs próduce tHeiV^arma^~l^gic effect bv interactinp Withł intraceilular receptora?

(A) leyotjiyroxine (B) yitamin D (C) estrogens (D) glucocorticoids (E) alhof the drugs -

&B (E) all


44. The ćlinical effectiyeness of a drug depends on its:

fA) maximaJ efficacy    r (C) potenc

are correct 45. If a drug elimination is of first order:

■“^A^ą constant amount of drug is eliminated in unit time (B) the capacity of metabolic process is limited (C) the danger of drug toxicity is higher flfflfhe ratę of elimination is directly proportionate to the drug concentration (E) A&B&C are correct

ł|

" 46. Actiyation of beta'2 receptgr is characteristic feature of: •

(A) dopamine (B) norepinephrine (C) epinenhrine (D) A&B&C (E) Nonę of them

ipppp    ,

- 47: A drug combination with high risk of adverse effects is: *

% (A) gemfibrozil+cTólestyrarnine (B) simvastadne+chólestyfaminę (C) niacin+colestipol (D)

' •• simvaststine+fenobibrate (E) lovastatin+ezetimibe

>»48tBisphQsphonatesfeg. Alendronate') are used in the treatment of:    '    . ■ i

fAl^^teoporesis (BI Paget disease (C) hypercalcemia ofmalignancy (D) A&B are correct (E) all are correct

-» 4^ Second generation of HI receptor antagonist is:

(A) promethazine (B) ęromolyn (C) dimenhydrinate (D) clemastine^|^yy|^^

A The inhihition of D2 recepto^ hv rlasdę^l-f^wftleptins-rftp. rhlnmrnmam^ d^not

Pcause: (A) antipsychotic effect (BI inhibition of yomiting (C) hyperprolactinemi*^drops in blood pressure (E) symptoms of Parkinson diseas.

Sl.atypical neuroleptics(olanzapine) differ fiom classical with respect to:

£A)the action on particular symptoms (BYThe effect on negatiye symptoms of schizophrenia (C) efScacy in nonresponsive patients (D)side effects e)all arę.

52. all of the following anticancer drugs are cfilLspecifiocexcept:

fA) cisplatin (B)docetaxel (C) paclitaxei (D) bleomycin

53.decide when pharmacoeconomic analysis of the cost-effectiveness type is indicated:

(B)the new drug is cheaper and kas worse clinical outcome results the new drug is.nhftaper and bas hetter rlinical outcome results

(D) the new drug is cheaper and has the same clinical outcome results

(E) the new drug is costlier and has worse clinical outcome results

Mjwhich of the following effects of morphine is of central origin:    olfyy1^

^(Ajmyosis (B) urinaryretention (C) hypotension (D)constipation (E) bronchoconstriction

te


Wyszukiwarka

Podobne podstrony:
DSC06971 Ryc. 191. Widok miejsca opracowania (2007) Fig. 191. View of the place of study (2007) Fig.
DSC06971 Ryc. 191. Widok miejsca opracowania (2007) Fig. 191. View of the place of study (2007) Fig.
img074 PHENOBARBITALUMFENOBARBITAL Pheaobarbital, PhenobarbitaL Nazwa chemiczna:
SNC03859 temp* zakwaszania gleb, korozji konstrukcji metalowych K^Sninu kwaśny deszcz (acid raiń) po
img6 (9) Reguły ACID ACID to skrót od czterech angielskich stów opisujących właściwości transakcji:
2.    Heat effect of the neutralization reaction of weak acid
Jabłońska-Ryś E., Zalewska-Korona M., Kalbarczyk J. 2009. Antioxidant capacity, ascorbic acid and ph
Przykładowy wykres [3- Kyplot] Effect of Iow Na+ on high K+-evoked amino acid release Release (pmol/
IMG70 (5) “Otder* AEDs Phenobarbital    1912 D’1antin (phenytoin)
skanuj0036 4 VI. NlE7.COr>NOŻC! RECEPTUROWE - INCO.WATIBIIJTATftS 2-39 Przykłady: 41. Kp. Phenoba
netter120 ienal Produclion of New HCO,RENAL PHYSIOLOGY NH4A - acid Net Acid txcretion(NAE)«(UuxV) -
netter135 Gastric Secretion: IGASTROINTESTINAL PHYSIOLOGY Neurocrine Regulalion of Acid
netter136 Gaslric Secretion: IIGASTROINTESTINAL PHYSIOLOGY Secrelions of gastric acid (H* ) by parie

więcej podobnych podstron